World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
47483
World Ranking
5743
National Ranking
320

Eckhard Thiel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eckhard Thiel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 869 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eckhard Thiel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eckhard Thiel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eckhard Thiel is primarily affiliated with Charité - University Medicine Berlin in Germany. Their research is predominantly situated within the field of Medicine, with a particular focus on Oncology, Epidemiology, Hematology, Pulmonary and Respiratory Medicine, and Infectious Diseases.

The scientist has contributed to several topics, particularly in areas concerning neutropenia and cancer infections, Pneumocystis jirovecii pneumonia detection and treatment, lymphoma diagnosis and treatment, antifungal resistance and susceptibility, fungal infections and studies, acute myeloid leukemia research, and chronic lymphocytic leukemia research.

Prominent recent papers authored by or involving Eckhard Thiel include:

  • "Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial" (2020, The Lancet. Gastroenterology & Hepatology)
  • "Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry" (2020, Journal of Cancer Research and Clinical Oncology)
  • "Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)" (2020, Annals of Hematology)
  • "Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)" (2021, Annals of Hematology)
  • "Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)" (2023, Journal of Antimicrobial Chemotherapy)

Eckhard Thiel frequently collaborates with several researchers, including:

  • Andreas Hochhaus (6 publications)
  • Christoph Kahl (5 publications)
  • Olaf Penack (5 publications)
  • Martin Schmidt-Hieber (5 publications)
  • Oliver A. Cornely (5 publications)

The scientist frequently publishes in several venues, including:

  • Annals of Hematology (8 publications)
  • Oncology Research and Treatment (6 publications)
  • Leukemia (3 publications)
  • European Journal of Cancer (2 publications)
  • InFo Hämatologie + Onkologie (2 publications)

Best Publications

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

    Gero Hütter;Daniel Nowak;Maximilian Mossner;Susanne Ganepola

  • Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot

  • Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

    Kristina Allers;Gero Hütter;Jörg Hofmann;Christoph Loddenkemper

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes

    H. W. Löms Ziegler-Heitbroc;Eckhard Thiel;Agnes Futterer;Volker Herzog

  • Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

    D Hoelzer;E Thiel;H Loffler;T Buchner

  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz

  • Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

    Monika Brüggemann;Thorsten Raff;Thomas Flohr;Nicola Gökbuget

  • Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

    Nicola Gökbuget;Michael Kneba;Thorsten Raff;Heiko Trautmann

  • Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

    Wilhelm Küker;Thomas Nägele;Agnieska Korfel;Stefan Heckl

  • Improved outcome in central nervous system aspergillosis, using voriconazole treatment.

    Stefan Schwartz;Markus Ruhnke;Patricia Ribaud;Lawrence Corey

  • Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis

    Beate Gleißner;Nicola Gökbuget;Claus R. Bartram;Bart Janssen

  • Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults.

    D Hoelzer;E Thiel;H Loffler;H Bodenstein

  • Improved outcome in adult B-cell acute lymphoblastic leukemia

    D Hoelzer;W D Ludwig;E Thiel;W Gassmann

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    Ulrich Keilholz;Anne Letsch;Antonia Busse;Anne Marie Asemissen

  • Presence of Wilms' Tumor Gene (wt1) Transcripts and the WT1 Nuclear Protein in the Majority of Human Acute Leukemias

    Menssen Hd;Renkl Hj;Rodeck U;Maurer J

  • Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

    J. Maurer;E. Thiel;W.-D. Ludwig;J.W.G. Janssen

  • Intestinal Non-Hodgkin’s Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin’s Lymphoma

    Severin Daum;Reiner Ullrich;Walter Heise;Bettina Dederke

  • Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

    Michael Hallek;Irmgard Langenmayer;Christoph Nerl;Wolfgang Knauf

Frequent Co-Authors

Ulrich Keilholz
Ulrich Keilholz Charité - University Medicine Berlin
Dieter Hoelzer
Dieter Hoelzer Goethe University Frankfurt
Carmen Scheibenbogen
Carmen Scheibenbogen Charité - University Medicine Berlin
Peter Martus
Peter Martus University of Tübingen
Michael Weller
Michael Weller University of Zurich
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Harald Stein
Harald Stein Charité - University Medicine Berlin
Hubert Serve
Hubert Serve Goethe University Frankfurt
Richard Reinhardt
Richard Reinhardt Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always require a traditional MD path. Today, there are several cahme accredited mha online programs for those interested in healthcare administration. These programs offer flexibility and a strong reputation for quality, making them ideal for future healthcare leaders.

For registered nurses eager to advance, many universities now offer rn to bsn programs without clinicals. These degrees streamline the process, removing the need for additional hands-on requirements for experienced professionals.

Those seeking the highest clinical degree in nursing can consider the fastest online dnp programs. These programs help advanced practice nurses reach their goals more quickly while maintaining high academic standards.

Cost is a common concern for many students, making cheapest dnp program options especially attractive. These affordable online degrees provide paths to top clinical and leadership roles in healthcare. Whether you focus on management, hands-on care, or research, online learning can create new opportunities in the U.S. medical field.

Best Scientists Citing Eckhard Thiel

Trending Scientists